MCPyV mRNA was detected using the following primers: 1) small T-forward 59-CCCCACGTCAGACAGTTTTT-39; small T-reverse 59-TTGTCTCGCCAGCATTGTAG-39; 2) large T-forward: 59-ATTGGGTGTGCTGGATTCTC-39; large T-reverse: 59-AGCAGAGAGGAGACCACCAA-39; and 3) large Tforward: 59-CTGGACTGGGAGTCTGAAGC-39; large T-reverse: 59-CTGGGTATGGGTCCTTCTCA-39.
Because MCPyV status affects MCC prognosis and to avoid confounding, 1 we excluded the 5 MCPyV
À
MCCs from further risk stratification by immunohistochemistry. NK cells in MCPyV 1 MCC tumors were visualized by CD16 immunohistochemistry (clone DJ130c; Santa Cruz Biotechnology, Santa Cruz, CA). CD56, another NK cell marker, is prominently expressed in MCC tumor cells and was therefore avoided.
3 NK cell infiltration into the MCC tumor was assessed by an investigator blinded to the SLN and overall survival outcome and graded as no/few infiltrating NK cells or moderate/many infiltrating NK cells (Fig 1) .
The average age of diagnosis for MCC was (Table I) . Seven of 10 patients (70%) with no/few infiltrating NK cells had a positive SLN, whereas 1 of 8 patients (12.5%) with moderate/ many infiltrating NK cells had a positive SLN (Fisher exact test, P ¼ .02). Four patients with MCPyV 1 MCC tumors had widely metastatic MCC or were deceased from MCC; these patients were from the cohort of patients with no/few NK cells. None of the patients with moderate/many tumor infiltrating NK cells developed distant metastasis or died of MCC. Follow-up was on average twice as long in the group with moderate/many infiltrating NK cells, primarily because of shorter survival in the group with no/few infiltrating NK cells. In summary, our results suggest that the assessment of MCC-infiltrating NK cells at the time of diagnosis provides important prognostic information. Our findings differ from that of Sihto et al, 3 who found no prognostic significance related to NK cell infiltration. This may be because of the exclusion of MCPyV À MCCs in this study. Although the small sample size is a limitation of the study, the data suggest a critical role for NK cells in the MCC antitumor immune response.
